See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 948: Real-World Evaluation of Supraflex Family SES: 12-Month Outcomes in the First 5,000 Patients from the S-FLEX Netherlands Registry

Presenter: Rohit Oemrawsingh

October 27, 2025

Presentation TCT 2025

TCT 1203: Sex Inequities in Cardiac Rehabilitation After Acute Coronary Syndrome: A Systematic Review of Clinical and Functional Outcomes

Presenter: Pablo Juan Salvadores

October 27, 2025

Presentation TCT 2025

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

Presenter: Xiaochun Zhang

October 27, 2025

Presentation TCT 2025

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Presenter: Suhail Dohad

October 27, 2025

Presentation TCT 2025

Introduction to HyperVue and DeepOCT+NIRS Imaging

Presenter: Kevin J. Croce

October 27, 2025

Presentation TCT 2025

Reperfuse First and Avoid Bleeding

Presenter: Vijay Kunadian

October 27, 2025

Presentation TCT 2025

TCT 725: First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Venous Closure: ELITE Venous Study

Presenter: Antigone Kostea

October 27, 2025

Presentation TCT 2025

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

Presenter: Fabien Praz

October 27, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Advertisement

Slides

TCT 948: Real-World Evaluation of Supraflex Family SES: 12-Month Outcomes in the First 5,000 Patients from the S-FLEX Netherlands Registry

TCT 1203: Sex Inequities in Cardiac Rehabilitation After Acute Coronary Syndrome: A Systematic Review of Clinical and Functional Outcomes

Comparing Outcomes of Transcatheter Tricuspid Valve Annuloplasty and Medical Therapy for Tricuspid Regurgitation: A Randomized Controlled Trial

In Intermediate-risk PE, What Measurable Improvements Can Catheter-Based Therapy Offer Over Anticoagulation??

Introduction to HyperVue and DeepOCT+NIRS Imaging

Reperfuse First and Avoid Bleeding

TCT 725: First in Man (FIM) Experience of the Vivasure PerQseal® ELITE System for Large Hole Venous Closure: ELITE Venous Study

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

The Intersection of Heart Failure and Mitral Valve Disease – The Conundrum of Managing Functional Mitral Regurgitation

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content